Release Products Faster Than With Conventional Batched Systems

In a screening world where more and more pathogens require screening before the release of blood products, the portfolio of Procleix systems allow for back-to-back assay testing within the same worklist to ensure faster time to a full set of results.

  • Back-to-back results from the same sample when multiple assay results are needed Allow for more efficient management of the daily workload
  • Process up to four assays from the same sample, at the same time, on the same system
  • Allow for more efficient management of the daily workload

Reduce Costs

The costs for recruiting donors and waste disposal are often overlooked. The Procleix assay portfolio helps blood banks reduce the cost of NAT screening.

  • Low input sample volume (0.5 mL needed per test) reduces the need to draw more sample from the blood bag
  • Single-tube processing means less solid waste to dispose of, not to mention less moving parts and maintenance
  • Isothermal TMA technology – better reproducibility
  • Reduce hazardous liquid disposal costs – liquid waste can be poured down the drain
  • Up to 24 months shelf life means less lot release validation and easier inventory management

Comprehensive Assay Menu

The Procleix assay portfolio contains a comprehensive menu of assays that meets the current NAT testing needs around the world.

  • Broad and expanding assay menu
  • Rapid response to emerging needs for blood safety worldwide
  • Isothermal TMA technology eliminates the need for thermocycling, which is used in PCR
  • Long shelf life and larger master lots lead to less variability in results

This information is intended for physicians and healthcare professionals only.

Product registration and availability vary by country. For more information on product availability, please contact us here.